3,811
Views
57
CrossRef citations to date
0
Altmetric
Research Article

Curcumin alleviates diabetic nephropathy via inhibiting podocyte mesenchymal transdifferentiation and inducing autophagy in rats and MPC5 cells

, , , , & ORCID Icon
Pages 778-786 | Received 01 Jul 2019, Accepted 30 Oct 2019, Published online: 19 Nov 2019

References

  • Guo J, Li J, Zhao J, Yang S, Wang L, Cheng G, Liu D, Xiao J, Liu Z, Zhao Z. 2017. MiRNA-29c regulates the expression of inflammatory cytokines in diabetic nephropathy by targeting tristetraprolin. Sci Rep. 7(1):2314–2329.
  • Huang J, Tian R, Yang Y, Jiang R, Dai J, Tang L, Zhang L. 2017. The SIRT1 inhibitor EX-527 suppresses mTOR activation and alleviates acute lung injury in mice with endotoxiemia. Innate Immun. 23(8):678–686.
  • Jeenger MK, Shrivastava S, Yerra VG, Naidu VG, Ramakrishna S, Kumar A. 2015. Curcumin: a pleiotropic phytonutrient in diabetic complications. Nutrition. 31(2):276–282.
  • Kim H, Dusabimana T, Kim SR, Je J, Jeong K, Kang MC, Cho KM, Kim HJ, Park SW. 2018. Supplementation of abelmoschus manihot ameliorates diabetic nephropathy and hepatic steatosis by activating autophagy in mice. Nutrients. 10(11):1703–1716.
  • Kim BH, Lee ES, Choi R, Nawaboot J, Lee MY, Lee EY, Kim HS, Chung CH. 2016. Protective effects of curcumin on renal oxidative stress and lipid metabolism in a rat model of type 2 diabetic nephropathy. Yonsei Med J. 57(3):664–673.
  • Li D, Lu Z, Jia J, Zheng Z, Lin S. 2013. Curcumin ameliorates podocytic adhesive capacity damage under mechanical stress by inhibiting miR-124 expression. Kidney Blood Press Res. 38(1):61–71.
  • Liu Y, Zhang J, Wang Y, Zeng X. 2017. Apelin involved in progression of diabetic nephropathy by inhibiting autophagy in podocytes. Cell Death Dis. 8(8):e3006.
  • Lu M, Yin N, Liu W, Cui X, Chen S, Wang E. 2017. Curcumin ameliorates diabetic nephropathy by suppressing NLRP3 inflammasome signaling. Biomed Res Int. 2017(7):1–10.
  • Marikanty RK, Gupta MK, Cherukuvada SV, Kompella SS, Prayaga AK, Konda S, Polisetty RV, Idris MM, Rao PV, Chandak GR, et al. 2016. Identification of urinary proteins potentially associated with diabetic kidney disease. Indian J Nephrol. 26:434–445.
  • Parsamanesh N, Moossavi M, Bahrami A, Butler AE, Sahebkar A. 2018. Therapeutic potential of curcumin in diabetic complications. Pharmacol Res. 136:181–193.
  • Peng N, Meng N, Wang S, Zhao F, Zhao J, Su L, Zhang S, Zhang Y, Zhao B, Miao J. 2014. An activator of mTOR inhibits oxLDL-induced autophagy and apoptosis in vascular endothelial cells and restricts atherosclerosis in apolipoprotein E−/− mice. Sci Rep. 4(1):5519–5530.
  • Sharma S, Kulkarni SK, Chopra K. 2006. Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol. 33(10):940–945.
  • Sheng YL, Chen X, Hou XO, Yuan X, Yuan BS, Yuan YQ, Zhang QL, Cao X, Liu CF, Luo WF, et al. 2017. Urate promotes SNCA/alpha-synuclein clearance via regulating mTOR-dependent macroautophagy. Exp Neurol. 297:138–147.
  • Simonson MS. 2007. Phenotypic transitions and fibrosis in diabetic nephropathy. Kidney Int. 71(9):846–854.
  • Soetikno V, Suzuki K, Veeraveedu PT, Arumugam S, Lakshmanan AP, Sone H, Watanabe K. 2013. Molecular understanding of curcumin in diabetic nephropathy. Drug Discov Today. 18(15–16):756–763.
  • Soetikno V, Watanabe K, Sari FR, Harima M, Thandavarayan RA, Veeraveedu PT, Arozal W, Sukumaran V, Lakshmanan AP, Arumugam S, et al. 2011. Curcumin attenuates diabetic nephropathy by inhibiting PKC-alpha and PKC-beta1 activity in streptozotocin-induced type I diabetic rats. Mol Nutr Food Res. 55(11):1655–1665.
  • Sun LN, Chen ZX, Liu XC, Liu HY, Guan GJ, Liu G. 2014. Curcumin ameliorates epithelial-to-mesenchymal transition of podocytes in vivo and in vitro via regulating caveolin-1. Biomed Pharmacother. 68(8):1079–1088.
  • Sun LN, Liu XC, Chen XJ, Guan GJ, Liu G. 2016. Curcumin attenuates high glucose-induced podocyte apoptosis by regulating functional connections between caveolin-1 phosphorylation and ROS. Acta Pharmacol Sin. 37(5):645–655.
  • Wang X, Gao Y, Gao J, Li M, Zhou M, Wang J, Pang Y, Cheng H, Yuan C, Chu Y, et al. 2019. Rheb1 loss leads to increased hematopoietic stem cell proliferation and myeloid-biased differentiation in vivo. Haematologica. 104(2):245–255.
  • Wang X, Li M, Gao Y, Gao J, Yang W, Liang H, Ji Q, Li Y, Liu H, Huang J, et al. 2016. Rheb1-mTORC1 maintains macrophage differentiation and phagocytosis in mice. Exp Cell Res. 344(2):219–228.
  • Wei Y, Gao J, Qin L, Xu Y, Shi H, Qu L, Liu Y, Xu T, Liu T. 2017. Curcumin suppresses AGEs induced apoptosis in tubular epithelial cells via protective autophagy. Exp Ther Med. 14:6052–6058.
  • World Health Organizadtion (WHO). 2016. Global report on diabetes. [accessed 2016 Apr]. https://www.who.int/diabetes/global-report/en/.
  • Wu W, Geng H, Liu Z, Li H, Zhu Z. 2014. Effect of curcumin on rats/mice with diabetic nephropathy: a systematic review and meta-analysis of randomized controlled trials. J Tradit Chin Med. 34(4):419–429.
  • Wu F, Li S, Zhang N, Huang W, Li X, Wang M, Bai D, Han B. 2018. Hispidulin alleviates high-glucose-induced podocyte injury by regulating protective autophagy. Biomed Pharmacother. 104:307–314.
  • Wu K, Tian R, Huang J, Yang Y, Dai J, Jiang R, Zhang L. 2018. Metformin alleviated endotoxemia-induced acute lung injury via restoring AMPK-dependent suppression of mTOR. Chem Biol Interact. 291(8):1–6.